Jacques Durant
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 41
- HIV/AIDS Research and Interventions 16
- Virology 25
- HIV Research and Treatment 24
- Co-authors
- P. Dellamonica (55 shared papers)Philippe Albert Clevenbergh (12 shared papers)Philippe Halfon (6 shared papers)Nathalie Montagne (5 shared papers)CAB Boucher (2 shared papers)Pascal Del-Giudice (1 shared paper)Pere Simonet (2 shared papers)R. Garraffo (12 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (11 papers)AIDS (6 papers)Clinical Infectious Diseases (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)Frontiers in Medicine (4 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Jacques Durant
108 papers receiving 2.8k citations
Jacques Durant's Hit Papers
Peers
Comparison fields: 5 of 112
- Virology 1.2k
- Infectious Diseases 1.9k
- Emergency Medicine 266
- Hepatology 169
- Epidemiology 436
Countries citing papers authored by Jacques Durant
This map shows the geographic impact of Jacques Durant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Durant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Durant more than expected).
Fields of papers citing papers by Jacques Durant
This network shows the impact of papers produced by Jacques Durant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Durant. The network helps show where Jacques Durant may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques Durant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial Hit paper breakdown → | 1999 | 618 |
| 2 | 2014 | 279 | |
| 3 | 2012 | 264 | |
| 4 | 2000 | 194 | |
| 5 | 2000 | 98 | |
| 6 | 2002 | 82 | |
| 7 | 2009 | 75 | |
| 8 | 2013 | 56 | |
| 9 | 2013 | 54 | |
| 10 | 2022 | 49 | |
| 11 | 2002 | 48 | |
| 12 | 2002 | 44 | |
| 13 | 2011 | 40 | |
| 14 | 2017 | 36 | |
| 15 | 2000 | 33 | |
| 16 | 1993 | 31 | |
| 17 | 2013 | 30 | |
| 18 | 2006 | 29 | |
| 19 | 2015 | 27 | |
| 20 | 1998 | 26 |
About Jacques Durant
Jacques Durant is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Hepatology and Epidemiology, having authored 112 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (41 papers), HIV Research and Treatment (24 papers), HIV/AIDS Research and Interventions (16 papers), HIV-related health complications and treatments (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Hepatitis C virus research (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Virology (1.2k citations), Infectious Diseases (1.9k citations), Emergency Medicine (266 citations), Hepatology (169 citations) and Epidemiology (436 citations). Jacques Durant has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include P. Dellamonica, Philippe Albert Clevenbergh, Philippe Halfon, Nathalie Montagne, CAB Boucher, Pascal Del-Giudice, Pere Simonet, R. Garraffo, Pascal Del Giudice and Jonathan Schapiro. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, AIDS, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.